Erlotinib (Compound)

Synonyms:Erlotinib, 183321-74-6, Tarceva, N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine, Erlotinib free base, 4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline, OSI-774, 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, Erlotinib, Free Base, N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine, 183321-74-6 (free base), NSC 718781, CHEMBL553, J4T82NDH7E, [6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE, CP358774, CP-358,774, DTXSID8046454, CHEBI:114785, MFCD02089651, RG-1415, NCGC00164574-01, [6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine, CP-35877401, R-1415, DTXCID6026454, Erlotinib(Tarceva), OSI-744, CAS-183321-74-6, NSC718781, Erlotinib [INN:BAN], SR-05000001460, UNII-J4T82NDH7E, erlotinibum, Erotinib, HSDB 8082, OSI 744, nchembio866-comp3, Kinome_3317, n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine monohydrochloride, ERLOTINIB [MI], ERLOTINIB [VANDF], R 1415, ERLOTINIB [WHO-DD], SCHEMBL8413, ERLOTINIB [EMA EPAR], BDBM5446, cid_176870, GTPL4920, HMS2089F05, HMS3244M19, HMS3244M20, HMS3244N19, HMS3295A19, HMS3713C22, HMS3745M05, Tox21_112202, AC-399, NSC800097, s7786, STK623143, AKOS000282911, Tox21_112202_1, CCG-220420, CS-0620, DB00530, NSC-800097, Ro-508231, SB16916, NCGC00164574-03, NCGC00164574-05, NCGC00164574-06, NCGC00164574-14, NCGC00164574-25, AS-35132, BCB03_000783, BE164419, HY-50896, SY028059, AM20090621, FT-0651539, R1415, EN300-708808, K00241, AB01273955-01, AB01273955-02, AB01273955-03, Q418369, SR-05000001460-1, SR-05000001460-2, SR-05000001460-3, SR-05000001460-6, BRD-K70401845-003-04-7, Z2588038919, 1429636-49-6

Pubchem:PUBCHEM:176870

Id:987bd2ed-9f97-55ad-8dd2-8b392e754380

Description:nan